Patents by Inventor Martin Edward Judge

Martin Edward Judge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of GLP-1 Peptides
    Publication number: 20110028391
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: October 15, 2010
    Publication date: February 3, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Use of GLP-1 Peptides
    Publication number: 20100113363
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: January 4, 2010
    Publication date: May 6, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Use of GLP-1 Peptides
    Publication number: 20090149387
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: February 12, 2009
    Publication date: June 11, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Use of GLP-1 peptides
    Publication number: 20030232754
    Abstract: GLP-1(1-45) or a fragment or an analogue thereof can be used in the preparation of a medicament for peripheral administration in the suppression of appetite or induction of satiety.
    Type: Application
    Filed: March 6, 2003
    Publication date: December 18, 2003
    Inventors: Jens Juul Holst, Arne Vernon Astrup, Martin Edward Judge, Liselotte Bjerre Knudsen, Lars Thim, Birgitte Schjellerup Wulff
  • Polypeptide with appetite regulating activity
    Publication number: 20030187187
    Abstract: The present invention relates to a polypeptide with appetite regulating function/activity, a nucleic acid construct encoding the polypeptide and a method of producing the polypeptide. The invention further relates to recombinant vectors comprising the nucleic acid construct encoding the polypeptide, recombinant host cells comprising the nucleic acid construct or the recombinant vector.
    Type: Application
    Filed: August 26, 2002
    Publication date: October 2, 2003
    Inventors: Sven Hastrup, Kennet Christiansen, Lars Thim, Martin Edward Judge, Peter Kristensen
  • Polypeptide with appetite regulating activity
    Patent number: 6458927
    Abstract: The present invention relates to a polypeptide with appetite regulating function/activity, a nucleic acid construct encoding the polypeptide and a method of producing the polypeptide. The invention further relates to recombinant vectors comprising the nucleic acid construct encoding the polypeptide, recombinant host cells comprising the nucleic acid construct or the recombinant vector.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: October 1, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Sven Hastrup, Kennet Christiansen, Lars Thim, Martin Edward Judge, Peter Kristensen
  • POLYPEPTIDE WITH APPETITE REGULATING ACTIVITY
    Publication number: 20020037845
    Abstract: The present invention relates to a polypeptide with appetite regulating function/activity, a nucleic acid construct encoding the polypeptide and a method of producing the polypeptide. The invention further relates to recombinant vectors comprising the nucleic acid construct encoding the polypeptide, recombinant host cells comprising the nucleic acid construct or the recombinant vector.
    Type: Application
    Filed: March 26, 1998
    Publication date: March 28, 2002
    Inventors: SVEN HASTRUP, KENNET CHRISTIANSEN, LARS THIM, MARTIN EDWARD JUDGE, PETER KRISTENSEN
  • Use of a pharmaceutical composition comprising an appetite-suppressing peptide
    Patent number: 5912229
    Abstract: The present invention relates to appetite-suppressing peptides or an appetite-suppressing peptide-containing fraction for the treatment of obesity or type II diabetes.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: June 15, 1999
    Assignee: Novo Nordisk Als
    Inventors: Lars Thim, Birgitte Schjellerup Wulff, Martin Edward Judge, Ole Dragsbaek Madsen, Jens Juul Holst